This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Dirk Kersten
General Partner at Forbion

Profile

Dirk is a General Partner at Forbion and manages the Forbion Growth Opportunities Fund. Dirk is a physicist by training and previously worked as a Partner at Gilde Healthcare Partners, where he led their Boston/US operations. Furthermore Dirk was a Managing Director at INKEF Capital responsible for all healthcare investment activities. Dirk led a series of investments in Europe and the US, including: Dyne Therapeutics (NASDAQ: DYN) Ascendis Pharma (NASDAQ: ASND), Profibrix (acquired by MEDCO), Lanthio Pharma (acquired by Morphosys), Nightbalance (acquired by Philips) and SynOx Therapeutics (private).

Agenda Sessions

  • Pharma: Part 1

    11:35
  • Drug and medical device discovery and commercialization

    10:15